View in EDS HTML Full Text PDF Full Text

Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Saved in:
Bibliographic Details
Title: Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
Authors: Helsby N; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. n.helsby@auckland.ac.nz., Yong M; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Burns K; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Findlay M; Cancer Trials New Zealand, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Auckland Regional Cancer and Blood Service, Auckland City Hospital, Grafton, Auckland, New Zealand., Porter D; Auckland Regional Cancer and Blood Service, Auckland City Hospital, Grafton, Auckland, New Zealand.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Sep; Vol. 88 (3), pp. 533-542. Date of Electronic Publication: 2021 Jun 10.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34114066
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Helsby+N%22">Helsby N</searchLink>; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. n.helsby@auckland.ac.nz.<br /><searchLink fieldCode="AU" term="%22Yong+M%22">Yong M</searchLink>; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Burns+K%22">Burns K</searchLink>; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Findlay+M%22">Findlay M</searchLink>; Cancer Trials New Zealand, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Auckland Regional Cancer and Blood Service, Auckland City Hospital, Grafton, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Porter+D%22">Porter D</searchLink>; Auckland Regional Cancer and Blood Service, Auckland City Hospital, Grafton, Auckland, New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2021 Sep; Vol. 88 (3), pp. 533-542. <i>Date of Electronic Publication: </i>2021 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34114066
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-021-04307-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 533
    Titles:
      – TitleFull: Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Helsby N
      – PersonEntity:
          Name:
            NameFull: Yong M
      – PersonEntity:
          Name:
            NameFull: Burns K
      – PersonEntity:
          Name:
            NameFull: Findlay M
      – PersonEntity:
          Name:
            NameFull: Porter D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 88
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1